Quick10K

⚲

Kforce

Filings

10-Q	2020-09-30	Filed 2020-11-04
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-07
10-K	2019-12-31	Filed 2020-02-21
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-08-01
10-Q	2019-03-31	Filed 2019-05-02
10-K	2018-12-31	Filed 2019-02-22
10-Q	2018-09-30	Filed 2018-11-01
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-02-23
10-Q	2017-09-30	Filed 2017-11-01
10-Q	2017-06-30	Filed 2017-08-02
10-Q	2017-03-31	Filed 2017-05-03
10-K	2016-12-31	Filed 2017-02-24
10-Q	2016-09-30	Filed 2016-11-02
10-Q	2016-06-30	Filed 2016-08-03
10-Q	2016-03-31	Filed 2016-05-04
10-K	2015-12-31	Filed 2016-02-26
10-Q	2015-09-30	Filed 2015-11-04
10-Q	2015-06-30	Filed 2015-08-05
10-Q	2015-03-31	Filed 2015-04-30
10-K	2014-12-31	Filed 2015-02-27
10-Q	2014-09-30	Filed 2014-10-30
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-04-30
10-K	2013-12-31	Filed 2014-02-27
10-Q	2013-09-30	Filed 2013-10-30
10-Q	2013-06-30	Filed 2013-07-31
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-02-22
10-Q	2012-09-30	Filed 2012-11-06
10-Q	2012-06-30	Filed 2012-08-08
10-Q	2012-03-31	Filed 2012-05-07
10-K	2011-12-31	Filed 2012-03-08
10-Q	2011-09-30	Filed 2011-11-02
10-Q	2011-06-30	Filed 2011-08-04
10-Q	2011-03-31	Filed 2011-05-04
10-K	2010-12-31	Filed 2011-03-04
10-Q	2010-09-30	Filed 2010-11-02
10-Q	2010-06-30	Filed 2010-08-04
10-Q	2010-03-31	Filed 2010-05-05
10-K	2009-12-31	Filed 2010-03-05

Reports

8-K	2020-11-04
8-K	2020-11-02
8-K	2020-09-21
8-K	2020-08-10
8-K	2020-05-06
8-K	2020-04-28
8-K	2020-04-16
8-K	2020-03-13
8-K	2020-02-05
8-K	2020-01-30
8-K	2019-12-03
8-K	2019-10-30
8-K	2019-09-12
8-K	2019-07-31
8-K	2019-06-07
8-K	2019-05-01
8-K	2019-04-25
8-K	2019-04-23
8-K	2019-04-01
8-K	2019-03-06
8-K	2019-02-28
8-K	2019-02-06
8-K	2019-01-31
8-K	2018-12-26
8-K	2018-11-21
8-K	2018-10-31
8-K	2018-08-24
8-K	2018-08-01
8-K	2018-05-01
8-K	2018-04-26
8-K	2018-03-15
8-K	2018-02-06

Kforce Financials

KFRC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	1	1	1	1	5	1	1	1	1	1	1	1	1	1	2	2	1	1	1	1	1	1	3	4	1	0	0	0	0	0	0	65	41
Accounts Receivable	167	175	173	179	169	152	164	165	182	179	188	201	202	205	203	215	216	199	210	216	209	206	228	225	244	226	238	239	238	235	221	226	228
Inventory
PP&E	36	36	35	36	35	57	36	36	37	61	36	36	36	61	35	36	38	66	38	38	42	73	43	42	41	72	39	39	37	68	29	29	30
Assets	405	410	409	369	353	325	341	345	362	348	352	366	355	364	360	372	373	352	360	370	369	365	389	390	406	384	389	394	392	380	425	426	409
Accounts Payable						23				19				22				24				20	19	19	19	22	21	26	24	23	21	21	21
Long-Term Debt
Liabilities	147	177	160	153	136	155	173	185	198	191	191	218	179	225	223	234	230	212	239	239	240	244	264	255	264	250	255	244	228	212	246	211	221
Stockholders' Equity	258	233	250	216	217	170	168	160	164	157	161	148	175	139	137	138	142	140	122	131	129	122	125	135	142	134	134	150	164	168	179	215	188


Income Statement ($MM)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	274		268	274	270	270	266	284	300	303	305	333	314	319	313	337	342	328	322	335	336	326	334	340	341	343	346	359	355	358	327	339	346
Cost of Revenue	187		188	184	181	181	182	191	202	207	214	236	216	220	218	231	232	224	225	229	231	226	237	236	237	240	246	251	251	251	234	238	243
Gross Profit	87		81	90	89	89	83	93	97	96	91	103	98	98	95	106	110	104	97	106	105	100	97	104	104	103	100	107	104	107	93	101	103
R&D
SG&A	72		108	71	70	73	76	84	79	90	78	83	82	81	82	83	84	81	86	86	88	82	85	83	82	82	85	82	80		80	78	79
Tax	4		1	2	6	6	2	7	6	3	4	7	5	5	4	8	9	8	5	7	6	6	3	7	9	9	3	6	5		3	5	5
Net Income	7		4	-33	9	6	3	7	9	-8	6	11	65	9	6	12	14	12	4	11	9	9	6	11	10	6	9	16	16	16	27	75	15


Cash Flow ($MM)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			2	5	20	28	-8	7	5	-3	6	6		-29	11	15	29	15	3	13	14	10	-11	16	0	24	10	28	26		12	11	24
Cash Investing			46	-1	6	1	-2	-2	-2	-2	-1	-1		-4	-1	-2	-4	-1	-1	-2	-6	-3	-2	-2	-0	-0	-1	-2	0		-2	114	-3
Cash Financing			-49	-4	-22	-33	10	-5	-3	5	-5	-5		33	-9	-13	-25	-14	-2	-11	-8	-7	14	-13	-3	-24	-9	-26	-27		-9	-59	-45